One scientist may have cracked the code to curing Alzheimer’s and Parkinson’s—using a single molecular switch.

Scientific research has traditionally been a slow and careful process. Scientists spend years testing ideas and doing ...

Faizah Alabi is a Nigerian US-based PhD student at the Texas Tech University Health Center in the United States, where she researches ways to treat leukaemia. As a pharmaceutical scientist in the ...

AI will deliver transformative therapies at an exponential scale, addressing the complexities of biology that traditional ...

Enantiomers, or molecule pairs that are mirror images of each other, make up more than half of FDA-approved drugs in use ...

Quantum-enhanced drug discovery emerges as a leading investment trend within the pharmaceutical sector for 2025. Since the ...

Collaboration combines Nuclera's eProtein Discovery System, which accelerates protein expression, purification and ...

In the past, most targeted drug development efforts relied on single biomarkers, but cancer is far more complex. BostonGene’s ...

The pharmaceutical industry faces big challenges in drug discovery today – rising costs, high failure rates, and increasingly complex target diseases.

Study suggests gasdermin D inhibition may protect mice by blocking release of cellular contents into the extracellular ...

Microsoft Scientific Discovery is an AI-powered research-focused platform designed for scientists, research institutions, and ...

Colorado BioScience Association (CBSA) commends the Colorado Office of Economic Development and International Trade (OEDIT) for awarding $3.135 Million in Commercialization Infrastructure grants under ...